JOSE VICENTE
CASTELL RIPOLL
EMÉRITO/A UNIVERSIDAD
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (76)
2024
-
A microRNA signature for valproate-induced steatosis in human hepatocytes and its application to predict fatty liver in paediatric epileptic patients on valproate therapy
Toxicology, Vol. 509
-
Assessing ATR-FTIR spectroscopy for steatosis quantification in liver biopsies in a long-duration cross-sectional study
Microchemical Journal, Vol. 198
-
Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways
International Journal of Molecular Sciences, Vol. 25, Núm. 10
-
Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis
International Journal of Molecular Sciences, Vol. 25, Núm. 5
-
Progress and challenges of mid-infrared spectroscopy for liver characterization focusing on steatosis, fibrosis and cancer
Applied Spectroscopy Reviews, Vol. 59, Núm. 4, pp. 578-599
-
Uncovering the toxicity mechanisms of a series of carboxylic acids in liver cells through computational and experimental approaches
Toxicology, Vol. 504
2023
-
A robust reprogramming strategy for generating hepatocyte-like cells usable in pharmaco-toxicological studies
Stem Cell Research and Therapy, Vol. 14, Núm. 1
-
Comparing the direct assessment of steatosis in liver explants with mid- and near-infrared vibrational spectroscopy, prior to organ transplantation
The Analyst, Vol. 148, Núm. 17, pp. 3986-3991
-
Enhancing the accuracy of mid-infrared spectroscopy-based liver steatosis quantification using digital image analysis as a reference
Analyst, Vol. 148, Núm. 13, pp. 3097-3106
-
Gut Microbiota and Plasma Bile Acids Associated with Non-Alcoholic Fatty Liver Disease Resolution in Bariatric Surgery Patients
Nutrients, Vol. 15, Núm. 14
-
Metabolomics-based strategy to assess drug hepatotoxicity and uncover the mechanisms of hepatotoxicity involved
Archives of Toxicology, Vol. 97, Núm. 6, pp. 1723-1738
-
The assessment of the potential hepatotoxicity of new drugs by in vitro metabolomics
Frontiers in Pharmacology, Vol. 14
2022
-
A Novel UPLC-MS Metabolomic Analysis-Based Strategy to Monitor the Course and Extent of iPSC Differentiation to Hepatocytes
Journal of Proteome Research, Vol. 21, Núm. 3, pp. 702-712
-
Methionine Cycle Rewiring by Targeting miR-873-5p Modulates Ammonia Metabolism to Protect the Liver from Acetaminophen
Antioxidants, Vol. 11, Núm. 5
-
Modeling a Novel Variant of Glycogenosis IXa Using a Clonal Inducible Reprogramming System to Generate “Diseased” Hepatocytes for Accurate Diagnosis
Journal of Personalized Medicine, Vol. 12, Núm. 7
-
Quantitative Prediction of Steatosis in Patients with Non-Alcoholic Fatty Liver by Means of Hepatic MicroRNAs Present in Serum and Correlating with Hepatic Fat
International journal of molecular sciences, Vol. 23, Núm. 16
-
The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment
Metabolites, Vol. 12, Núm. 6
2021
-
Extracting consistent biological information from functional results of metabolomic pathway analysis using the Mantel's test
Analytica Chimica Acta, Vol. 1187
-
Factors that influence the quality of metabolomics data in in vitro cell toxicity studies: a systematic survey
Scientific Reports, Vol. 11, Núm. 1
-
Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes
Archives of Toxicology, Vol. 95, Núm. 9, pp. 3049-3062